Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 5816-5825

  Chackerian, Bryce ^a,c   Durfee, Marisa R ^a   Schiller, John T ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CELL MARKER; EPITOPE; LYSOZYME; VIRUS ANTIGEN; AUTOANTIBODY; BIOLOGICAL MARKER; FREUND ADJUVANT; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CLONAL ANERGY; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; VIRUS LIKE AGENT; ADOPTIVE TRANSFER; ANIMAL; BOVINE PAPILLOMAVIRUS TYPE 1; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOLOGY; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BOVINE PAPILLOMAVIRUS 1; CD4-POSITIVE T-LYMPHOCYTES; CLONAL ANERGY; FREUND'S ADJUVANT; HUMAN PAPILLOMAVIRUS 16; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, B-CELL; UP-REGULATION;

EID: 44449151190     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.5816     Document Type: Article

References (45)

1. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377. (Pubitemid 37075812)
2. Nemazee, D. 2000. Receptor editing in B cells. Adv. Immunol. 74: 89-126.
3. Casellas, R., T. A. Shih, M. Kleinewietfeld, J. Rakonjac, D. Nemazee, K. Rajewsky, and M. C. Nussenzweig. 2001. Contribution of receptor editing to the antibody repertoire. Science 291: 1541-1544. (Pubitemid 32179219)
4. Halverson, R., R. M. Torres, and R. Pelanda. 2004. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat. Immunol. 5: 645-650. (Pubitemid 38811890)
5. Fulcher, D. A., and A. Basten. 1994. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J. Exp. Med. 179: 125-134. (Pubitemid 24012977)
6. Cyster, J. G., S. B. Hartley, and C. C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371: 389-395. (Pubitemid 24302553)
7. Merrell, K. T., R. J. Benschop, S. B. Gauld, K. Aviszus, D. Decote-Ricardo, L. J. Wysocki, and J. C. Cambier. 2006. Identification of anergic B cells within a wild-type repertoire. Immunity 25: 953-962.
8. Bachmann, M. F., and M. R. Dyer. 2004. Therapeutic vaccination for chronic diseases: a new class of drugs in sight. Nat. Rev. Drug Discov. 3: 81-88. (Pubitemid 38088700)
9. Dintzis, H. M., R. Z. Dintzis, and B. Vogelstein. 1976. Molecular determinants of immunogenicity: the immunon model of immune response. Proc. Natl. Acad. Sci. USA 73: 3671-3675.
10. Chackerian, B. 2007. Virus-like particles: flexible platforms for vaccine development. Expert Rev. Vaccines. 6: 381-390. (Pubitemid 46911601)
11. Chackerian, B., D. R. Lowy, and J. T. Schiller. 1999. Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles. Proc. Natl. Acad. Sci. USA 96: 2373-2378. (Pubitemid 29117922)
12. Chackerian, B., D. R. Lowy, and J. T. Schiller. 2001. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J. Clin. Invest. 108: 415-423. (Pubitemid 32730788)
13. Fehr, T., M. F. Bachmann, E. Bucher, U. Kalinke, F. E. Di Padova, A. B. Lang, H. Hengartner, and R. M. Zinkernagel. 1997. Role of repetitive antigen patterns for induction of antibodies against antibodies. J. Exp. Med. 185: 1785-1792. (Pubitemid 27242200)
14. Jennings, G. T., and M. F. Bachmann. 2007. Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines. Curr. Mol. Med. 7: 143-155. (Pubitemid 46488187)
15. Chackerian, B., P. Lenz, D. R. Lowy, and J. T. Schiller. 2002. Determinants of autoantibody induction by conjugated papillomavirus virus-like particles. J. Immunol. 169: 6120-6126. (Pubitemid 36903455)
16. Yang, R., F. M. Murillo, M. J. Delannoy, R. L. Blosser, W. H. t. Yutzy, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. Roden. 2005. B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88. J. Immunol. 174: 7912-7919.
17. Dintzis, R. Z., M. H. Middleton, and H. M. Dintzis. 1983. Studies on the immunogenicity and tolerogenicity of T-independent antigens. J. Immunol. 131: 2196-2203.
18. Dintzis, R. Z., M. Okajima, M. H. Middleton, G. Greene, and H. M. Dintzis. 1989. The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. J. Immunol. 143: 1239-1244. (Pubitemid 19211354)
19. Cooke, M. P., A. W. Heath, K. M. Shokat, Y. Zeng, F. D. Finkelman, P. S. Linsley, M. Howard, and C. C. Goodnow. 1994. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179: 425-438. (Pubitemid 24058730)
20. Goodnow, C. C. 1992. Transgenic mice and analysis of B-cell tolerance. Annu. Rev. Immunol. 10: 489-518.
21. Buck, C. B., C. D. Thompson, Y. Y. Pang, D. R. Lowy, and J. T. Schiller. 2005. Maturation of papillomavirus capsids. J. Virol. 79: 2839-2846. (Pubitemid 40270562)
22. Buck, C. B., D. V. Pastrana, D. R. Lowy, and J. T. Schiller. 2004. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 78: 751-757. (Pubitemid 38067597)
23. Lenz, P., C. D. Thompson, P. M. Day, S. M. Bacot, D. R. Lowy, and J. T. Schiller. 2003. Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells. Clin. Immunol. 106: 231-237. (Pubitemid 36428995)
24. Chackerian, B., M. Rangel, Z. Hunter, and D. S. Peabody. 2006. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-β without concomitant T cell responses. Vaccine 24: 6321-6331. (Pubitemid 44247237)
25. Alters, S. E., K. Sakai, L. Steinman, and V. T. Oi. 1990. Mechanisms of anti-CD4-mediated depletion and immunotherapy: a study using a set of chimeric anti-CD4 antibodies. J. Immunol. 144: 4587-4592.
26. Gammon, G., N. Shastri, J. Cogswell, S. Wilbur, S. Sadegh-Nasseri, U. Krzych, A. Miller, and E. Sercarz. 1987. The choice of T-cell epitopes used on a protein antigen depends on multiple factors distant from, as well as at the determinant site. Immunol. Rev. 98: 53-73. (Pubitemid 17128065)
27. Goodnow, C. C., J. Crosbie, H. Jorgensen, R. A. Brink, and A. Basten. 1989. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 342: 385-391. (Pubitemid 19277513)
28. Eris, J. M., A. Basten, R. Brink, K. Doherty, M. R. Kehry, and P. D. Hodgkin. 1994. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc. Natl. Acad. Sci. USA 91: 4392-4396. (Pubitemid 24143439)
29. Wheeler, K., J. D. Pound, J. Gordon, and R. Jefferis. 1993. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur. J. Immunol. 23: 1165-1168. (Pubitemid 23120182)
30. Snapper, C. M., M. R. Kehry, B. E. Castle, and J. J. Mond. 1995. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells: a redefinition of the TI-2 vs T cell-dependent antigen dichotomy. J. Immunol. 154: 1177-1187.
31. Pierce, S. K. 2002. Lipid rafts and B-cell activation. Nat. Rev. Immunol. 2: 96-105. (Pubitemid 37323233)
32. Thyagarajan, R., N. Arunkumar, and W. Song. 2003. Polyvalent antigens stabilize B cell antigen receptor surface signaling microdomains. J. Immunol. 170: 6099-6106. (Pubitemid 36682592)
33. Phan, T. G., M. Amesbury, S. Gardam, J. Crosbie, J. Hasbold, P. D. Hodgkin, A. Basten, and R. Brink. 2003. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J. Exp. Med. 197: 845-860. (Pubitemid 36437862)
34. Wang, Y., and A. M. Krieg. 2004. Induction of autoantibody production but not autoimmune disease in HEL transgenic mice vaccinated with HEL in combination with CpG or control oligodeoxynucleotides. Vaccine 22: 2641-2650. (Pubitemid 38757368)
35. Morris, S. C., M. Moroldo, E. H. Giannini, T. Orekhova, and F. D. Finkelman. 2000. In vivo survival of autoreactive B cells: characterization of long-lived B cells. J. Immunol. 164: 3035-3046. (Pubitemid 30148963)
36. Cambier, J. C., S. B. Gauld, K. T. Merrell, and B. J. Vilen. 2007. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. Immunol. 7: 633-643. (Pubitemid 47123549)
37. Eaton, S. M., E. M. Burns, K. Kusser, T. D. Randall, and L. Haynes. 2004. Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J. Exp. Med. 200: 1613-1622. (Pubitemid 40094185)
38. Casellas, R., Q. Zhang, N. Y. Zheng, M. D. Mathias, K. Smith, and P. C. Wilson. 2007. Igκ allelic inclusion is a consequence of receptor editing. J. Exp. Med. 204: 153-160. (Pubitemid 46148765)
39. Chackerian, B., L. Briglio, P. S. Albert, D. R. Lowy, and J. T. Schiller. 2004. Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus. J. Virol. 78: 4037-4047. (Pubitemid 38437210)
40. Ambuhl, P. M., A. C. Tissot, A. Fulurija, P. Maurer, J. Nussberger, R. Sabat, V. Nief, C. Schellekens, K. Sladko, K. Roubicek, et al. 2007. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. J. Hypertens. 25: 63-72.
41. Rohn, T. A., G. T. Jennings, M. Hernandez, P. Grest, M. Beck, Y. Zou, M. Kopf, and M. F. Bachmann. 2006. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol. 36: 2857-2867.
42. Sonderegger, I., T. A. Rohn, M. O. Kurrer, G. Iezzi, Y. Zou, R. A. Kastelein, M. F. Bachmann, and M. Kopf. 2006. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur. J. Immunol. 36: 2849-2856.
43. Spohn, G., R. Guler, P. Johansen, I. Keller, M. Jacobs, M. Beck, F. Rohner, M. Bauer, K. Dietmeier, T. M. Kundig, et al. 2007. A virus-like particle-based vaccine selectively targeting soluble TNF-α protects from arthritis without inducing reactivation of latent tuberculosis. J. Immunol. 178: 7450-7457. (Pubitemid 46847473)
44. Paus, D., T. G. Phan, T. D. Chan, S. Gardam, A. Basten, and R. Brink. 2006. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J. Exp. Med. 203: 1081-1091.
45. Storni, T., C. Ruedl, K. Schwarz, R. A. Schwendener, W. A. Renner, and M. F. Bachmann. 2004. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J. Immunol. 172: 1777-1785. (Pubitemid 38116826)